ENDRA Life Sciences Inc. Common Stock (NDRA) Stock Price

NDRAStock

$4.75+3.99%52W

Market Cap$7.12M

P/E—

PEG Ratio—

Div yield—

Beta-0.10

NDRA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)20.93%

Price vs S&P 500 (4W)-0.81%

VGM Score36.33

Book Value / Share (Quarterly)$1.44

P/TBV (Annual)21.12x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-6.46

Price vs S&P 500 (YTD)-11.30%

Gross Margin (TTM)51.35%

Net Profit Margin (TTM)-2016.22%

EPS (TTM)$-7.75

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-7.75

EPS (Annual)$-8.93

ROI (Annual)-310.93%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-20124.55%

Cash / Share (Quarterly)$0.29

ROA (Last FY)-182.35%

EBITD / Share (TTM)$-6.79

ROE (5Y Avg)-245.08%

Operating Margin (TTM)-1921.62%

Cash Flow / Share (Annual)$-6.97

P/B Ratio3.14x

P/B Ratio (Quarterly)3.23x

Net Income / Employee (Annual)$-638,900

EV / Revenue (TTM)14.21x

Net Interest Coverage (TTM)-50.00x

ROA (TTM)-242.13%

EPS Incl Extra (Annual)$-8.93

Current Ratio (Annual)1.29x

Quick Ratio (Quarterly)0.43x

3-Month Avg Trading Volume0.03M

52-Week Price Return3.99%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.21

P/S Ratio (Annual)561.37x

Asset Turnover (Annual)0.00x

52-Week High$9.85

Operating Margin (5Y Avg)-18450.33%

EPS Excl Extra (Annual)$-8.93

CapEx CAGR (5Y)106.68%

Tangible BV CAGR (5Y)6.43%

26-Week Price Return32.17%

Quick Ratio (Annual)1.02x

13-Week Price Return-14.77%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.64x

Enterprise Value$5.26M

Asset Turnover (TTM)0.06x

Book Value / Share Growth (5Y)-14.53%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)0.00x

Pretax Margin (Annual)-98000.00%

Cash / Share (Annual)$0.65

3-Month Return Std Dev111.63%

Gross Margin (5Y Avg)62.27%

Net Income / Employee (TTM)$-663,900

ROE (Last FY)-310.93%

EPS Basic Excl Extra (Annual)$-8.93

Receivables Turnover (TTM)2.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-7.75

ROI (TTM)-513.22%

P/S Ratio (TTM)15.17x

Pretax Margin (5Y Avg)-20124.55%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.21

Price vs S&P 500 (52W)-14.32%

Year-to-Date Return0.66%

5-Day Price Return1.11%

EPS Normalized (Annual)$-8.93

ROA (5Y Avg)-163.84%

Net Profit Margin (Annual)-98000.00%

Month-to-Date Return-2.98%

Cash Flow / Share (TTM)$-2.35

EBITD / Share (Annual)$-7.27

Operating Margin (Annual)-90200.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-244.69%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-7.75

P/TBV (Quarterly)21.12x

P/B Ratio (Annual)2.34x

Inventory Turnover (TTM)0.00x

Pretax Margin (TTM)-2016.22%

Book Value / Share (Annual)$1.92

Price vs S&P 500 (13W)-17.56%

Beta-0.10x

Revenue / Share (TTM)$0.00

ROE (TTM)-513.22%

52-Week Low$2.96

vGradeD

mGradeC

vgmGradeD

NDRA Earnings Surprise History

Q2 25-1.71est. -2.27

Q3 25-2.10est. -1.95

Q4 25-2.23est. -1.23

Q1 26-1.09est. -1.23

Q2 26-1.17est. -0.84

NDRA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
NDRAENDRA Life Sciences Inc. Common Stock	D	—	C	$4.75
MDTMedtronic plc	B	C	C	$91.14
LIVNLivaNova PLC Ordinary Shares	C	B	B	$79.41
ITGRInteger Holdings Corporation	C	C	B	$125.39
TMDXTransMedics Group, Inc. Common Stock	C	B	C	$93.60
AXGNAxogen, Inc. Common Stock	F	B	B	$49.93
BLFSBioLife Solutions Inc.	D	C	A	$37.22
CNMDCONMED Corporation	B	C	B	$51.13
CBLLCeriBell, Inc. Common Stock	D	A	B	$23.95
INMDInMode Ltd. Ordinary Shares	A	D	C	$15.03
ELMDElectromed, Inc.	D	B	B	$39.34
CVCapsoVision, Inc. Common Stock	F	D	C	$5.85
STEXStreamex Corp. Common Stock	—	C	F	$0.76
FOCLEDAP TMS S.A. American Depositary Shares	C	B	C	$4.39
STXSStereotaxis, Inc. Common Stock	D	D	D	$1.41
VANIVivani Medical, Inc. Common Stock (DE)	—	—	C	$1.42
HYPRHyperfine, Inc. Class A Common Stock	C	A	D	$0.87
ECORelectroCore, Inc. Common Stock	C	A	B	$9.47
OMOutset Medical, Inc. Common Stock	A	C	D	$4.30
NRXSNeuraxis, Inc.	F	B	C	$6.04
POCIPrecision Optics Corporation, Inc. Common Stock	C	A	C	$4.41
QTIQT Imaging Holdings, Inc. Common Stock	D	A	D	$3.24
IRIXIridex Corp	B	D	D	$0.72
NXLNexalin Technology, Inc. Common Stock	D	C	D	$0.32
ITOCiTonic Holdings Ltd Class A Ordinary Shares	—	A	C	$0.27
NUWENuwellis, Inc. Common Stock	A	D	F	$0.96
EDAPEDAP TMS SA	C	B	C	$4.18
EYESCorgi Data & Surveillance ETF	—	C	C	$29.06
FONRFonar Corporation	B	D	C	$0.00
MASIMasimo Corporation	D	D	C	$0.00
QSIAWQuantum-Si Incorporated Warrant	—	—	F	$0.00
TIVCTivic Health Systems, Inc. Common Stock	—	B	F	$0.17

About ENDRA Life Sciences Inc. Common Stock

ENDRA Life Sciences develops Thermo Acoustic Enhanced Ultrasound (TAEUS), a point-of-care imaging technology that delivers MRI-quality tissue visualization at ultrasound cost using existing ultrasound systems globally. The company is initially targeting assessment of fatty liver disease (NAFLD/NASH), which affects over 1 billion people worldwide with no practical diagnostic tools currently available. Additional applications include thermal imaging during energy-based surgical procedures.